Literature DB >> 19714650

Induction of apoptosis in the synovium of mice with autoantibody-mediated arthritis by the intraarticular injection of double-stranded MicroRNA-15a.

Yoshihiko Nagata1, Tomoyuki Nakasa, Yu Mochizuki, Masakazu Ishikawa, Shigeru Miyaki, Hayatoshi Shibuya, Keiichiro Yamasaki, Nobuo Adachi, Hiroshi Asahara, Mitsuo Ochi.   

Abstract

OBJECTIVE: MicroRNA is a family of noncoding RNAs that exhibit tissue-specific or developmental stage-specific expression patterns and are associated with human diseases. MicroRNA-15a (miR-15a) is reported to induce cell apoptosis by negatively regulating the expression of Bcl-2, which suppresses the apoptotic processes. The purpose of this study was to investigate whether double-stranded miR-15a administered by intraarticular injection could be taken up by cells and could induce Bcl-2 dysfunction and cell apoptosis in the synovium of arthritic mice in vivo.
METHODS: Autoantibody-mediated arthritis was induced in male DBA/1J mice. In the experimental group, double-stranded miR-15a labeled with FAM-atelocollagen complex was injected into the knee joint. In the control group, control small interfering RNA-atelocollagen complex was injected into the knee joint. Synovial expression of miR-15a was analyzed by quantitative polymerase chain reaction, FAM by fluorescence microscopy, Bcl-2 by Western blotting, and Bcl-2 and caspase 3 by immunohistochemistry.
RESULTS: The expression of miR-15a in the synovium of the experimental group was significantly higher than that in the control group. Green fluorescence emission of FAM was observed in the synovium of the experimental group. Bcl-2 protein was down-regulated and the expression of caspase 3 was increased as compared with that in the control group.
CONCLUSION: These results indicate that the induction of cell apoptosis after intraarticular injection of double-stranded miR-15a occurs through inhibition of the translation of Bcl-2 protein in arthritic synovium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19714650     DOI: 10.1002/art.24762

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  28 in total

Review 1.  Nanotherapeutic approaches for the treatment of rheumatoid arthritis.

Authors:  Christine T N Pham
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2011-08-11

Review 2.  [MicroRNAs in B-cells and T-cells as regulators of inflammation].

Authors:  J Wittmann; H-M Jäck; M-F Mashreghi
Journal:  Z Rheumatol       Date:  2011-08       Impact factor: 1.372

3.  The effect of microRNA-21 on proliferation and matrix synthesis of chondrocytes embedded in atelocollagen gel.

Authors:  Wirat Kongcharoensombat; Tomoyuki Nakasa; Masakazu Ishikawa; Atsuo Nakamae; Masataka Deie; Nobuo Adachi; Abouheif Mohamed; Mitsuo Ochi
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-03-27       Impact factor: 4.342

Review 4.  Deregulation and therapeutic potential of microRNAs in arthritic diseases.

Authors:  Rita Vicente; Danièle Noël; Yves-Marie Pers; Florence Apparailly; Christian Jorgensen
Journal:  Nat Rev Rheumatol       Date:  2015-12-24       Impact factor: 20.543

Review 5.  Macro view of microRNA function in osteoarthritis.

Authors:  Shigeru Miyaki; Hiroshi Asahara
Journal:  Nat Rev Rheumatol       Date:  2012-08-14       Impact factor: 20.543

6.  Altered microRNA expression signature in Chikungunya-infected mammalian fibroblast cells.

Authors:  Deepti Parashar; Mandar S Paingankar; Ashwini More; Poonam Patil; Sarika Amdekar
Journal:  Virus Genes       Date:  2018-06-05       Impact factor: 2.332

Review 7.  Epigenetics in rheumatoid arthritis: a primer for rheumatologists.

Authors:  Nunzio Bottini; Gary S Firestein
Journal:  Curr Rheumatol Rep       Date:  2013-11       Impact factor: 4.592

Review 8.  The discovery of novel experimental therapies for inflammatory arthritis.

Authors:  Charles J Malemud
Journal:  Mediators Inflamm       Date:  2010-03-18       Impact factor: 4.711

9.  MicroRNA-146a expresses in interleukin-17 producing T cells in rheumatoid arthritis patients.

Authors:  Takuya Niimoto; Tomoyuki Nakasa; Masakazu Ishikawa; Atsushi Okuhara; Bunichiro Izumi; Masataka Deie; Osami Suzuki; Nobuo Adachi; Mitsuo Ochi
Journal:  BMC Musculoskelet Disord       Date:  2010-09-15       Impact factor: 2.362

10.  Utility of Select Plasma MicroRNA for Disease and Cardiovascular Risk Assessment in Patients with Rheumatoid Arthritis.

Authors:  Michelle J Ormseth; Joseph F Solus; Kasey C Vickers; Annette M Oeser; Paolo Raggi; C Michael Stein
Journal:  J Rheumatol       Date:  2015-08-01       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.